Embolization Particle Market Size by Particles, Application, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2032
Overview
The Embolization Particle Market size was valued at USD 2.30 Billion in 2025 and the total Embolization Particle revenue is expected to grow at a CAGR of 9.1% from 2025 to 2032, reaching nearly USD 4.24 Billion by 2032.
To know about the Research Methodology :- Request Free Sample Report
Embolization Particle Market Definition
There raised occurrence of cancers and tumors is likely to drive the embolization particle marketplace over the forecast time period. The oncology segment is projected to grow at a CAGR of xx% during the forecast period owing to the upsurge in the incidence of most cancers globally has brought about robust expansion of the oncology segment. North America upholds the major share of the embolization particle market and is likely to reach USD 7xx.20 million by way of 2032.The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Embolization Particle Market Dynamics
Embolization is a slightly invasive therapy to stop bleeding along with to prevent blood flow to a tumor so as to shrink it or in preparation for elimination. In this method, some embolized particles or materials are injected into the veins of the sufferers to block or reduce the blood flow to cancer cells. Embolization is an alternative for some patients with tumors that cannot be eliminated by means of surgical operation.
There elevated incidence of cancers and tumors is probable to drive the embolization particle marketplace over the forecast time period. As per the National Cancer Institute 2018 Report, there have been round 1,735,350 new most cancer cases within the U.S. This variety is predicted to attain 23.6 million by 2030. Additionally, widespread technological improvements made in the healthcare enterprise are leading to diverse new product launches for the treatment of assorted chronic situations. Besides, the increasing attention among people about the embolization particle is in all likelihood to result in an increased demand for embolization debris over the anticipated time period. Furthermore, the growth inside the interventional process and upward thrust in the variety of minimally invasive surgical procedures due to advantageous and powerful effects are anticipated to assist the embolization particle marketplace within the years in advance.
However, the lack of skilled interventional cardiologists might restrict the embolization particle market in the future.
Embolization Particle Market Segment analysis
Based on the Application, the oncology segment is projected to grow at a CAGR of xx% during the forecast period. Though, the thriving in the superiority of cancer globally has led to a sturdy enlargement of the oncology section, that's predicted to record excessive growth for the duration of the forecast duration. The upsurge in the incidence of most cancers globally has brought about robust expansion of the oncology segment, which is expected to record high growth during the forecast period. According to Globocan, the incidence of liver cancer was 8.2% of the entire cancer occurrence in 2019, female breast cancer (11.6%), prostate most cancers (7.1%), and colorectal cancer (6.1%) Embolization debris is the primary products used in the remedy of malignancies. An increase in consciousness about uterine fibroid embolization strategies (UFE) and benign prostatic hyperplasia treatment via embolization is predicted to enhance the marketplace inside the following couple of years.
Embolization Particle Market Regional analysis
North America is anticipated to lead the worldwide embolization particle market at some point of the forecast duration. America maintains the biggest share of the embolization particle market and is likely to reach USD 7xx.20 million by way of 2032. The Americas lead the worldwide embolization particle market as a result of the presence of the sturdy economic condition, massive development in the healthcare domain, and the focus of studies establishments on updating technology for new and advanced diagnosis and treatment techniques. Moreover, advanced hospitals infrastructures and availability of skilled healthcare professional is similarly including stimulus to the boom of the market. In 2019, there will be approximately 140,690 cancer cases diagnosed and about 103,250 cancer deaths among the oldest old in the US. Cancer accounts for 8% of all cases diagnosed in the US but 17% of all cancer deaths.
Europe is a prominent area of the embolization particle marketplace because of a growth within the acceptance of slightly invasive processes for treatment. Embolization approaches have fewer facet-results because of their minimally invasive nature and faster wound healing process. The upward thrust in awareness amongst patients regarding embolization procedures and their related benefits inclusive of brief clinic stay and rapid healing procedure also contributes to market growth.
The objective of the report is to present a comprehensive analysis of the Global Embolization Particle Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Embolization Particle Market dynamics, structure by analysing the market segments and projects the Global Embolization Particle Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Embolization Particle Market make the report investor’s guide.
Scope of the Global Embolization Particle Market: Inquire before buying
| Global Embolization Particle Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 2.30 Bn. |
| Forecast Period 2026 to 2032 CAGR: | 9.1% | Market Size in 2032: | USD 4.24 Bn. |
| Segments Covered: | by Particles | Microspheres Particles Drug-Eluting Beads (DEBs) Radio-Embolic Microspheres |
|
| by Application | Trauma Embolization Peripheral Vascular Disease Liver Tumor Embolization oncology Uterine Fibroid Embolization Others |
||
Global Embolization Particle Market, By Regions
North America (United States, Canada, and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, ASEAN, Indonesia, Philippines, Malaysia, Vietnam, Thailand, ASEAN, Rest of Asia Pacific)
Middle East & Africa (South Africa, GCC, Nigeria, Rest of ME&A)
South America (Brazil, Argentina, Rest of South America)
Key Players operating the Global Embolization Particle Market
1. Sirtex Medical
2. Merit Medical
3. Cook Medical
4. BTG Medical
5. Boston Scientific Corporation
6. Terumo Corporation
7. HENGRUI Medical
8. INterface BIOmaterials B.V.
9. Alicon
10. Guerbet
11. Medtronics
12. Abbott Laboratories
13. Edwards Lifesciences
14. Johnson & Johnson
15. Pfizer, Inc.
16. St. Jude Medical, Inc.
Frequently Asked Questions:
1. Which region has the largest share in Global Embolization Particle Market?
Ans: Asia Pacific region holds the highest share in 2025.
2. What is the growth rate of Global Embolization Particle Market?
Ans: The Global Embolization Particle Market is growing at a CAGR of 9.1% during forecasting period 2026-2032.
3. What is scope of the Global Embolization Particle Market report?
Ans: Global Embolization Particle Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. What is the study period of this market?
Ans: The Global Embolization Particle Market is studied from 2025 to 2032.